UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000058500 |
|---|---|
| Receipt number | R000066883 |
| Scientific Title | A needs assessment is required to establish a disease-drug collaboration on inflammatory bowel disease. |
| Date of disclosure of the study information | 2025/07/17 |
| Last modified on | 2025/07/17 13:49:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A Needs Assessment of Information to Be Shared to Establish a Drug-Pharmacy Collaboration for Patients with Inflammatory Bowel Disease
Acronym
A needs assessment is required to establish a disease-drug collaboration on inflammatory bowel disease.
Scientific Title
A needs assessment is required to establish a disease-drug collaboration on inflammatory bowel disease.
Scientific Title:Acronym
Needs Assessment for the Establishment of a Disease-Drug Collaboration
Region
| Japan |
Condition
Condition
inflammatory bowel disease
Classification by specialty
| Gastroenterology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Investigate the information needs of pharmacists to establish IBD collaborations.
Basic objectives2
Others
Basic objectives -Others
Searching for the Causes of the Lack of Disease-Drug Collaboration in IBD
Trial characteristics_1
Others
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
Priority of information to be provided
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Pharmacists affiliated with pharmacies or hospitals in Hokkaido
Key exclusion criteria
None
Target sample size
365
Research contact person
Name of lead principal investigator
| 1st name | Kuninori |
| Middle name | |
| Last name | Iwayama |
Organization
Hokkaido University of Science
Division name
Faculty of Pharmaceutical Sciences
Zip code
006-8585
Address
15-4-1, Maeda 7-jo, Teine-ku, Sapporo-shi, Hokkaido 006-8585, Japan
TEL
0116768621
iwayama-k@hus.ac.jp
Public contact
Name of contact person
| 1st name | Kuninori |
| Middle name | |
| Last name | Iwayama |
Organization
Hokkaido University of Science
Division name
Faculty of Pharmaceutical Sciences
Zip code
006-8585
Address
15-4-1, Maeda 7-jo, Teine-ku, Sapporo-shi, Hokkaido 006-8585, Japan
TEL
0116768621
Homepage URL
iwayama-k@hus.ac.jp
Sponsor or person
Institute
Hokkaido University of Science
Institute
Department
Personal name
Kuninori Iwayama
Funding Source
Organization
Hokkaido University of Science
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
None
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
the Ethics Committee of the Hokkaido University of Science
Address
15-4-1, Maeda 7-jo, Teine-ku, Sapporo-shi, Hokkaido 006-8585, Japan
Tel
None
None
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 07 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 04 | Month | 24 | Day |
Date of IRB
| 2025 | Year | 06 | Month | 25 | Day |
Anticipated trial start date
| 2025 | Year | 07 | Month | 16 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Survey by questionnaire
Management information
Registered date
| 2025 | Year | 07 | Month | 17 | Day |
Last modified on
| 2025 | Year | 07 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066883
